Source: BioPortfolio

Formula Pharmaceuticals: Formula Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 17042018 Prices from USD $250

SummaryFormula Pharmaceuticals Inc Formula Pharmaceuticals is a biopharmaceutical company that develops chimeric antigen receptor immunotherapy for oncology and autoimmune diseases. The company provides its pipeline products such as CIKCAR.CD19 used as Bly...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Maurits W. Geerlings's photo - President & CEO of Formula Pharmaceuticals

President & CEO

Maurits W. Geerlings

CEO Approval Rating

70/100

Read more